Clover Biopharmaceuticals, Ltd.

Form D Filings

Location
Chengdu, China
Industry Group
Biotechnology
Related People
Peng Liang, Joshua Liang, Xiaodong Wang, Ting Xiao, Guangyu Xu, Dong Lyu
Entity Type
Corporation
CIK
0001856491
All SEC Filings
View on sec.gov
Date Filed Security Types Amount Sold Diff Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
4/28/2025 Equity, Option to Acquire $584,146 $904,859 $904,859 $0 4/2/2024 4/25/2025 D/A 000185649125000001
4/11/2024 Equity, Option to Acquire $320,713 $320,713 $320,713 $0 4/2/2024 4/11/2024 D 000185649124000005
5/9/2023 Equity, Option to Acquire $10,810,804 $48,882,447 Indefinite Indefinite 4/18/2021 5/9/2023 D/A 000110465923057396
5/24/2022 Equity, Option to Acquire $10,051,411 $48,123,054 Indefinite Indefinite 4/18/2021 5/24/2022 D/A 000110465922064094
4/28/2021 Equity $38,071,643 $38,071,643 Indefinite Indefinite 4/18/2021 4/28/2021 D 000110465921056432